跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
邱 弘毅
教授
,
公共衛生學系
合聘教授
,
醫務管理學系
合聘教授
,
高齡健康暨長期照護學系
合聘教授
,
臨床醫學研究所
合聘教授
,
醫學人文研究所
合聘教授
,
應用流行病學碩士學位學程
合聘教授
,
全球衛生暨衛生安全碩士學位學程
合聘教授
,
全球衛生暨衛生安全博士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
合聘教授
,
神經醫學博士學位學程
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
成員
,
臺北醫學大學神經醫學研究中心
https://orcid.org/0000-0002-4545-9697
電子郵件
hychiou
tmu.edu
tw
h-index
11543
引文
50
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1994 …
2026
每年研究成果
概覽
指紋
網路
專案
(112)
研究成果
(366)
資料集
(9)
類似的個人檔案
(8)
指紋
查看啟用 Hung-Yi Chiou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
79%
Malignant Neoplasm
62%
Well Water
62%
Brain Ischemia
53%
Chronic Kidney Failure
51%
Cigarette Smoking
47%
Disease
42%
Dose-Response Relationship
41%
Carotid Atherosclerosis
38%
Transitional Cell Carcinoma
36%
Bladder Cancer
35%
Lung Cancer
31%
Ischemic Heart Disease
25%
Blackfoot Disease
24%
Diabetes Mellitus
23%
Chemotherapy
23%
Prevalence
22%
Long Term Exposure
21%
Cardiovascular Disease
20%
Glutathione
18%
Transferase
17%
Injury
16%
Non Insulin Dependent Diabetes Mellitus
16%
Methanearsonic Acid
15%
Cerebrovascular Disease
15%
Ethanol
15%
Atherosclerosis
14%
Comorbidity
14%
Case-Control Study
14%
Overall Survival
14%
Deterioration
14%
Breast Cancer
13%
Urinary Tract Cancer
13%
Cisplatin
12%
Fluorouracil
12%
End Stage Renal Disease
12%
Advanced Glycation End Product Receptor
12%
Rheumatoid Arthritis
12%
Bevacizumab
12%
Colorectal Cancer
12%
Infection
11%
Cancer Registry
11%
Arginine
10%
Neoplasm
10%
Brain Hemorrhage
10%
Cerebrovascular Accident
10%
Biological Marker
9%
Skin Cancer
9%
Intestine Cancer
9%
Cacodylic Acid
9%
Medicine and Dentistry
Apoplexy
100%
Cohort Analysis
70%
Brain Ischemia
69%
Diabetes
36%
Malignant Neoplasm
35%
Chronic Kidney Disease
32%
Odds Ratio
31%
Disease
27%
Cigarette Smoking
25%
Carotid Atherosclerosis
24%
Hazard Ratio
22%
Well Water
22%
Percutaneous Thrombectomy
22%
Diabetes Mellitus
20%
Prevalence
20%
Transitional Cell Carcinoma
20%
Cerebral Hemorrhage
19%
Bladder Cancer
19%
Blackfoot Disease
18%
Ischemic Heart Disease
18%
Urinary System
18%
Dose Response
18%
COVID-19
17%
Case-Control Study
17%
Injury
16%
Breast Cancer
16%
Body Mass Index
15%
Methylation
14%
Diseases
14%
Lung Cancer
13%
Anemia
13%
Logistic Regression Analysis
13%
Proportional Hazards Model
13%
Hyperglycemia
13%
Kidney Function
13%
Infection
13%
Long-Term Care
12%
Systematic Review
12%
Geriatrics
12%
Advanced Glycation End Product Receptor
12%
Hemoglobin A1c
11%
Adolescent
10%
Cancer Risk
10%
Modified Rankin Scale
10%
Maturity Onset Diabetes of the Young
10%
Smoking
10%
Retrospective Cohort Study
10%
Study Subject
9%
Traumatic Brain Injury
9%
Intestine Cancer
9%
Nursing and Health Professions
Confidence Interval
52%
Cohort Analysis
36%
Odds Ratio
35%
Prevalence
21%
Adolescent
20%
Injury
19%
Traumatic Brain Injury
18%
Disease
18%
Cigarette Filter
18%
Brain Ischemia
17%
Health Care Personnel
14%
Long Term Care
13%
National Health Insurance
12%
Subacute Care
12%
Breast Cancer
12%
Blood Pressure
11%
Cerebrovascular Accident
11%
Mortality Rate
9%
Chronic Kidney Failure
9%
World Health Organization
9%
Tobacco Control
9%
Severe Acute Respiratory Syndrome
9%
Outpatient
9%
Independent Practice Association
9%
Hospital
8%
Comorbidity
8%
Disability
8%
Health Care Planning
8%
Psychiatrist
8%
Malpractice
8%
Total Quality Management
8%
Health Service
8%
Infrared Photography
8%
Lung Cancer
8%
Insulin Resistance
8%
Hypogonadism
8%
Clinical Outcome
8%
Human Immunodeficiency Virus
8%
Content Analysis
8%
Real-World Evidence
8%
Biobank
8%
Waist Circumference
7%
Rehabilitation Engineering
7%
Head Injury
7%
Cardiovascular Disease
7%
Teaching Hospital
7%
Survival Rate
7%
Bibliometrics
7%
Chronic Disease
6%
Body Mass
6%
